Status:
ACTIVE_NOT_RECRUITING
Topical Sulfasalazine and Oral Lichen Planus
Lead Sponsor:
Cairo University
Conditions:
Oral Lichen Planus
Topical Sulfasalazine
Eligibility:
All Genders
30-65 years
Phase:
PHASE3
Brief Summary
Oral lichen planus (OLP) is a chronic inflammatory disease that affects the mucosal membrane. T-cell mediated damage against the mucosal epithelial cells is implicated in the pathogenesis of OLP, altho...
Detailed Description
* Patients will be recruited in a consecutive manner from the outpatient Diagnostic center, Faculty of Dentistry, Cairo University. * A total number of 46 patients will be included in this study. The ...
Eligibility Criteria
Inclusion
- \- Patients with 30-65 years old
- Patents with atrophic OLP
Exclusion
- \- Smokers
- pregnant or lactating ladies and
- Patients under topical or systemic steroids during the last two months
- Patients using lichenoid reaction-inducing drugs,
- Patients with positive hepatitis C virus (HCV) antibodies, diabetes and hypertension
- Patients having amalgam filling adjacent lesions will not also be included
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06060301
Start Date
March 1 2023
End Date
October 20 2024
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Cairo University
Cairo, Egypt, 115